Quince Therapeutics (QNCX) Other Operating Expenses (2022 - 2026)
Quince Therapeutics (QNCX) posted quarterly Other Operating Expenses of $2.8 million for Q1 2026, up 122.67% year-over-year from $1.3 million in Q1 2025, and up 16.1% quarter-over-quarter from $2.5 million in Q4 2025.
Quince Therapeutics (QNCX) Other Operating Expenses (2022 - 2026) Analysis & Trends
Quince Therapeutics' Other Operating Expenses history runs 5 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 122.67% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $6.6 million (down 61.89% YoY), while the FY2025 annual figure was $5.0 million, down 71.77% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $2.8 million, up from $2.5 million in the prior quarter.
- The five-year high for Other Operating Expenses was $18.4 million in Q2 2024, with the low at -$3.5 million in Q3 2024.
- The 5-year median for Other Operating Expenses is $1.5 million (2023), against an average of $2.9 million.
- Peak annual rise in Other Operating Expenses reached 140.4% in 2025, while the deepest fall reached 100.83% in 2025.
- Quince Therapeutics' Other Operating Expenses stood at $825000.0 in 2022, then soared by 91.27% to $1.6 million in 2023, then slipped by 28.45% to $1.1 million in 2024, then surged by 117.27% to $2.5 million in 2025, then grew by 16.1% to $2.8 million in 2026.
- Business Quant data shows QNCX's Other Operating Expenses at $2.8 million in Q1 2026, $2.5 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quince Therapeutics | 203.43 Mn | 203.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.85 Mn |
| Dec 31, 2025 | 2.45 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | -152,000.00 |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | -3.53 Mn |
| Jun 30, 2024 | 18.38 Mn |
| Mar 31, 2024 | 2.55 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Mar 31, 2023 | 5.90 Mn |
| Sep 30, 2022 | 825,000.00 |